Local News: Hebei, China 

 | 

Sign Up

 | 

Sign In

Vertex Pharmaceuticals News Editors

News Widget

Display the Vertex Pharmaceuticals news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Vertex Pharmaceuticals News

News on Vertex Pharmaceuticals (Ticker: VRTX) continually updated from thousands of sources around the net.

16 hrs ago | PR-inside.com

Vertex Pharmaceuticals Incorporated a " Product Pipeline Review...

The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Fri Feb 10, 2012

Wall St. Cheat Sheet

Traders Analyze Earnings of These 2 Healthcare Stocks

InterMune, Inc. A reported a drop to a loss in the fourth quarter driven by higher costs.A Reported a loss of $44.5 million in the quarter.

Comment?

Related Topix: Biotech, InterMune, Medicine, Healthcare Industry, Financial Markets, Gilead Sciences, Startups, Idenix Pharmaceuticals

Harvard Crimson

New CF Drug Targets Protein

Vertex Pharmaceuticals, a Cambridge-based pharmaceutical company, received FDA approval last week for its new cystic fibrosis treatment.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Cambridge, MA, Vertex, Genetics

Thu Feb 09, 2012

Wall St. Cheat Sheet

Healthcare Stocks in Trading Spotlight Before Earnings

InterMune, Inc. A will unveil its latest earnings on Thursday, February 9, 2012.A The average estimate of analysts is for a loss of 71 cents per share, a wider loss from the year earlier quarter net loss of 39 cents.

Comment?

Related Topix: Biotech, InterMune, Medicine, Healthcare Industry, Financial Markets, Gilead Sciences, Startups, Idenix Pharmaceuticals

Wed Feb 08, 2012

Benzinga

's M&A Chatter for Wednesday February 8, 2012

The acquisition is expected to complement Akamai's market-leading site acceleration solutions with technology designed to optimize the speed at which a web page is rendered, regardless of end user device.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Akamai Technologies, Semiconductors, Micron Technology, Electronics, Research in Motion, Telecom, Computers, Vertex

Tue Feb 07, 2012

NatureNews

Drug bests cystic-fibrosis mutation

In a blinded clinical trial, neither the patient nor the clinician should know who is receiving placebo and who the active drug.

Comment?

Related Topix: Medicine, Cystic Fibrosis, Health, Fibrosis, Food and Drug Administration, New York, Kidney Cancer, Biotech, Healthcare Industry

Mon Feb 06, 2012

Boston Herald

Search for 'miracle' renewed

"It's a huge milestone," Richard Fitzpatrick, chief operating officer of the Flatley Discovery Lab, said of Vertex Pharmaceuticals' new drug, Kalydeco.

Comment?

Related Topix: Food and Drug Administration, Medicine, Cystic Fibrosis, Health, Fibrosis, Biotech, Healthcare Industry

Fri Feb 03, 2012

Examiner.com

Life saving drug approved for CF patients

On January 31st the Cystic Fibrosis Foundation announced that the life-saving drug Kalydeco has been approved by the FDA.

Comment?

Related Topix: Medicine, Cystic Fibrosis, Health, Charitable Organizations, Cystic Fibrosis Foundation, Healthcare Law, Law, Biotech, Healthcare Industry

The Motley Fool

Curing Diseases Makes For a Bad Business Model

The meteoric rise of its hepatitis C drug Incivek is even more impressive considering that it had to compete with Merck 's sold $865 million worth of Lipitor during its first year.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Johnson & Johnson, Johnson and Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals, Lipitor, Atorvastatin (generic), Medication

Benzinga

's M&A Chatter for Thursday February 2, 2012

The Deal : Walgreen and BioScrip announced Thursday that they have entered into a definitive agreement under which Walgreens would acquire certain assets of BioScrip's community specialty pharmacies and centralized specialty and mail service pharmacy businesses and BioScrip would receive a total deal value of approximately $225 million.

Comment?

Related Topix: BioScrip, Healthcare Industry, Walgreens, Retail, Research in Motion, Telecom, Computers, Biotech, Medicine, Achillion Pharmaceuticals, Pharmaceuticals

Seeking Alpha

Amylin Pharmaceuticals: There Are Better Investment Opportunities In Biotech

When a biotechnology company receives approval for a new drug, that is almost always a catalyst for a huge rally in that company's stock price.

Comment?

Related Topix: Biotech, Medicine, Amylin Pharmaceuticals, Healthcare Industry, Science / Technology, Food and Drug Administration, Diabetes, Health

Seeking Alpha

Vertex Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript

Good day, ladies and gentlemen, and welcome to the Vertex Pharmaceuticals Incorporated Fourth Quarter 2011 Financial Results Conference Call.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Thu Feb 02, 2012

Wall St. Cheat Sheet

Stock Analyst Insights Feb 2nd: CIGNA, Intuitive Surgical, Vertex

Intuitive Surgical, Inc. : Collins Stewart confirmed with Intuitive Surgical management that the Japanese Ministry of Health indicated da Vinci prostatectomy is scheduled to be reimbursed beginning in April.

Comment?

Related Topix: Startups, Intuitive Surgical, Biotech, Medicine, Healthcare Industry, Johnson and Johnson

Wall St. Cheat Sheet

Vertex Pharmaceuticals Incorporated Earnings: Swung to a Profit

Vertex Pharmaceuticals Incorporated reported its results for the fourth quarter.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Vertex

The Motley Fool

Maximum Market: $2.9 Billion, For Now

Both occurred well before their PDUFA dates, the date the FDA sets as a goal for making a decision about a product, which is a good sign for the entire drug-development industry.

Comment?

Related Topix: Medicine, Cystic Fibrosis, Health, Fibrosis, Genetics, Biotech, Healthcare Industry

CBS Local

Drug Approved To Treat Cystic Fibrosis' Root Cause

The first drug that treats the root cause of cystic fibrosis won approval Tuesday, offering a life-changing treatment for a handful of patients with the deadly illness and broader hope for thousands more patients with the inherited disease.

Comment?

Related Topix: Medicine, Cystic Fibrosis, Fibrosis, Biotech, Healthcare Industry, Genetics

Wed Feb 01, 2012

Wall St. Cheat Sheet

Merck, Gilead, and Vertex Trading Up as Investors Await Earnings

Merck & Co., Inc. will unveil its latest earnings on Thursday, February 2, 2012.

Comment?

Related Topix: Startups, Micrus, Chiron, Biotech, Merck , Medicine, Healthcare Industry, Gilead Sciences, Vertex

Stock Market Review

Early Approval for Vertex CF Drug - Analyst Blog

Vertex Pharmaceuticals Inc. 's shares jumped over 6% buoyed by news of the US Food and Drug Administration approving its lead pipeline candidate, Kalydeco , for treating patients suffering from cystic fibrosis .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Food and Drug Administration, Healthcare Law, Law

AmericanBankingNews.com

Credit Suisse (CS) Analysts Raise Vertex Pharmaceuticals (VRTX) EPS Estimates

Analysts at Credit Suisse boosted their EPS estimates on shares of Vertex Pharmaceuticals in a research report issued to clients and investors on Wednesday.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Vertex

The Motley Fool

3 Stocks to Get on Your Watchlist

I follow quite a lot of companies -- some more closely than others -- so the usefulness of a watchlist to me cannot be overstated.

Comment?

Related Topix: Financial Markets, The Motley Fool, Biotech, Medicine, Healthcare Industry, Johnson & Johnson, Johnson and Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals

Also on Topix